MedTrace Logo

Evaluation of COPD Co-Pilot

NCT02944591 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2018-03-29

No results posted yet for this study

Summary

The purpose of this research study is to investigate the potential benefits of participant use of a smartphone application ("App") called COPD Co-Pilot™. When used by the participant, COPD Co-Pilot™ may provide early detection of worsening COPD symptoms. Early symptom detection may allow the pulmonary providers and nurses to respond with timely medical advice and treatment. The goal for use of COPD Co-Pilot™ is to reduce the frequency and duration of hospitalizations, emergency department visits, and hospital readmissions. The study will also examine the financial impact of the COPD Co-Pilot™ program to determine whether costs of hospital stays, emergency department visits, and hospital readmissions differ when patients are enrolled in COPD Co-Pilot™ than when they are not enrolled. Another purpose of this study is to measure patient satisfaction with use of COPD Co-Pilot™.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DEVICE

COPD Co-Pilot

The COPD Co-PilotTM is a smartphone application for symptom reporting supported by a Call Center staffed with pulmonary nurses and Health Assistants who are trained to support patients with COPD. The call center staff are employees and subcontractors of the company that makes the COPD Co-PilotTM, HGE. It is located on the Campus of Temple University in Philadelphia Pennsylvania.

Sponsors & Collaborators

  • PneumRx, Inc.

    collaborator INDUSTRY

  • HGE Health Care Solutions, LLC

    lead INDUSTRY

Principal Investigators

  • Mark T Dransfield, MD · The University of Alabama at Birmingham

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-04-05
Completion
2018-04-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02944591 on ClinicalTrials.gov